Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.

Expert Rev Resp Med. 2007;1(3):307-316. Specific trials of erdosteine in geriatric subjects and in patients suffering from mild renal or hepatic failure did not show any impact on the rates of ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...